home / stock / crsp / crsp articles

CRSP Articles, CRISPR Therapeutics AG - From 02/22/24

Stock Information
Company Name: CRISPR Therapeutics AG
Stock Symbol: CRSP
Market: NASDAQ
Website: crisprtx.com
Menu
CRSP CRSP Quote CRSP Short CRSP News CRSP Articles CRSP Message Board
Get CRSP Alerts

News, Short Squeeze, Breakout and More Instantly...
Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
What's Going On With Crispr Therapeutics Stock? | Benzinga

Crispr Therapeutics (NASDAQ:CRSP) shares are trading higher Thursday after Wolfe Research analyst Andy Chen initiated coverage on Crispr Therapeuti...

Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday | Benzinga

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday. Shares of Reliance Steel & Aluminum Co. (N...

CRISPR Therapeutics to Present at the Citi 2024 Virtual Oncology Leadership Summit | Benzinga

ZUG, Switzerland and BOSTON, Feb. 15, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creatin...
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today | Benzinga

CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 4.96% on an annualized basis producing an average annual ret...

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today | Benzinga

CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 1.56% on an annualized basis producing an average annual ret...

Cathie Wood's Ark Invest Sells $8.04M Worth of DraftKings Shares | Benzinga

On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling a substantial portion of its stake in DraftKings Inc (NASDAQ:DKNG). T...
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule | Benzinga

Tuesday, the FDA approved CRISPR Therapeutics AG’s (NASDAQ:CRSP)/Vertex Pharmaceutical Incorporated’s (NASDAQ:VRTX) Casg...

Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units | Benzinga

On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO) units....

CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

ZUG, Switzerland and BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creatin...
Previous 10 Next 10